Seres Therapeutics, Inc. (MCRB)
USD 0.57
(-10.8%)
USD 0.57
(-10.8%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 125.62 Million USD | 1715.99% |
| 2022 | 6.12 Million USD | -95.72% |
| 2021 | 143.19 Million USD | 349.66% |
| 2020 | -57.35 Million USD | -25.68% |
| 2019 | -45.63 Million USD | 32.58% |
| 2018 | -67.68 Million USD | -18.02% |
| 2017 | -57.35 Million USD | 4.76% |
| 2016 | -60.22 Million USD | -8172.39% |
| 2015 | -728 Thousand USD | 93.21% |
| 2014 | -10.71 Million USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -1.42 Million USD | 8.92% |
| 2024 Q1 | -1.55 Million USD | 60.92% |
| 2023 Q1 | -4.12 Million USD | -14137.93% |
| 2023 Q3 | -209 Thousand USD | -100.17% |
| 2023 FY | 111.21 Million USD | 1715.99% |
| 2023 Q4 | -3.98 Million USD | -1808.61% |
| 2023 Q2 | 124.36 Million USD | 3112.04% |
| 2022 Q3 | -39.67 Million USD | 7.13% |
| 2022 Q2 | -42.71 Million USD | -8362.86% |
| 2022 Q1 | 517 Thousand USD | 101.75% |
| 2022 FY | 6.12 Million USD | -95.72% |
| 2022 Q4 | -29 Thousand USD | 99.93% |
| 2021 FY | 143.19 Million USD | 349.66% |
| 2021 Q2 | -30.69 Million USD | -30.13% |
| 2021 Q1 | -23.58 Million USD | -222.95% |
| 2021 Q4 | -29.53 Million USD | -123.51% |
| 2021 Q3 | 125.59 Million USD | 509.23% |
| 2020 Q2 | -14.05 Million USD | -3.69% |
| 2020 Q4 | -7.3 Million USD | 67.46% |
| 2020 FY | -57.35 Million USD | -25.68% |
| 2020 Q1 | -13.55 Million USD | -1.07% |
| 2020 Q3 | -22.44 Million USD | -59.7% |
| 2019 Q3 | -11.28 Million USD | -110.01% |
| 2019 Q4 | -13.41 Million USD | -18.82% |
| 2019 Q1 | -15.56 Million USD | -10.1% |
| 2019 Q2 | -5.37 Million USD | 65.48% |
| 2019 FY | -45.63 Million USD | 32.58% |
| 2018 Q3 | -14.62 Million USD | 24.8% |
| 2018 Q1 | -19.48 Million USD | 7.13% |
| 2018 FY | -67.68 Million USD | -18.02% |
| 2018 Q4 | -14.13 Million USD | 3.3% |
| 2018 Q2 | -19.44 Million USD | 0.25% |
| 2017 Q3 | 805 Thousand USD | 104.02% |
| 2017 Q4 | -20.98 Million USD | -2706.96% |
| 2017 FY | -57.35 Million USD | 4.76% |
| 2017 Q2 | -20.04 Million USD | -17.04% |
| 2017 Q1 | -17.12 Million USD | 0.53% |
| 2016 Q1 | -12.7 Million USD | 8.59% |
| 2016 Q2 | -19.17 Million USD | -50.87% |
| 2016 Q4 | -17.22 Million USD | -54.74% |
| 2016 Q3 | -11.12 Million USD | 41.95% |
| 2016 FY | -60.22 Million USD | -8172.39% |
| 2015 Q2 | -8.78 Million USD | -57.96% |
| 2015 Q4 | -13.9 Million USD | -41.12% |
| 2015 FY | -728 Thousand USD | 93.21% |
| 2015 Q3 | -9.85 Million USD | -12.14% |
| 2015 Q1 | -5.56 Million USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | -10.71 Million USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -230.364% |
| Alkermes plc | 1.37 Billion USD | 90.862% |
| Agenus Inc. | 139.61 Million USD | 10.023% |
| Aptorum Group Limited | -1.11 Million USD | 11369.611% |
| Ardelyx, Inc. | 106.66 Million USD | -17.776% |
| Dyadic International, Inc. | 922.95 Thousand USD | -13510.71% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -496.463% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 71947.886% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1040.428% |
| Novavax, Inc. | 639.93 Million USD | 80.37% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 368.197% |
| Pyxis Oncology, Inc. | -2 Million USD | 6381.05% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 24410.009% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -559.67% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 284387.589% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 23937.002% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 227.901% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -15563.466% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 153296.341% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 7.132% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1495.998% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 229.573% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 91.724% |
| AlloVir, Inc. | -398 Thousand USD | 31663.065% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 47.818% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -29527.594% |
| Bicycle Therapeutics plc | -129.52 Million USD | 196.99% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -104584.167% |
| ChromaDex Corporation | 50.78 Million USD | -147.383% |
| Chimerix, Inc. | 324 Thousand USD | -38671.914% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 503.049% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 261.887% |
| CRISPR Therapeutics AG | 240.95 Million USD | 47.866% |
| Precision BioSciences, Inc. | 40.47 Million USD | -210.39% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 227.972% |
| Fortress Biotech, Inc. | 57.85 Million USD | -117.138% |
| Fortress Biotech, Inc. | 57.85 Million USD | -117.138% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -657.803% |
| ImmuCell Corporation | 4.39 Million USD | -2757.436% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 218.373% |
| Immix Biopharma, Inc. | -5468.00 USD | 2297484.784% |
| Incyte Corporation | 3.44 Billion USD | 96.349% |
| Innoviva, Inc. | 261.06 Million USD | 51.881% |
| IO Biotech, Inc. | -756 Thousand USD | 16716.534% |
| Jaguar Health, Inc. | 7.72 Million USD | -1526.372% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 19018.825% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -4.9% |
| ContextLogic Inc. | 59 Million USD | -112.917% |
| MiMedx Group, Inc. | 266.84 Million USD | 52.923% |
| MEI Pharma, Inc. | 49.32 Million USD | -154.67% |
| NextCure, Inc. | -3.68 Million USD | 3509.908% |
| Onconetix, Inc. | -1.12 Million USD | 11244.863% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 533.654% |
| Opthea Limited | 21.72 Thousand USD | -578265.562% |
| Psyence Biomedical Ltd. | -240.00 USD | 52342183.333% |
| Vaxcyte, Inc. | -75 Million USD | 267.495% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 219234.424% |
| Precigen, Inc. | 106 Thousand USD | -118410.377% |
| Pharming Group N.V. | 220.1 Million USD | 42.927% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -24292.427% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -12350.05% |
| PureTech Health plc | -1.6 Million USD | 7936.619% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -14.438% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 169.248% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 377.156% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 671.342% |
| Acelyrin, Inc. | -115 Thousand USD | 109335.652% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1249935.837% |
| Summit Therapeutics Inc. | -2.05 Million USD | 6227.854% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 22100.175% |
| Senti Biosciences, Inc. | -2.68 Million USD | 4782.11% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -3000.987% |
| Elevation Oncology, Inc. | -39 Thousand USD | 322205.128% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 2718.195% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 3286.694% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -331.258% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -25226.815% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 228501.818% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -20.675% |
| Seer, Inc. | 7.02 Million USD | -1687.69% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -2769.37% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -483.063% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 106117.335% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 87762.333% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -20527.422% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -4.272% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 59.951% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 2512520.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -4780.381% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 247677.848% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -327.471% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 54246.983% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 25632.724% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 1869.808% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 26571.884% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1207994.231% |
| Soligenix, Inc. | 97.31 Thousand USD | -128992.292% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1262.189% |
| Kura Oncology, Inc. | -849 Thousand USD | 14896.349% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 287.203% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 85556.463% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -26.84% |
| Autolus Therapeutics plc | -4.86 Million USD | 2681.077% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -203.535% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 74874.405% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -32.619% |
| GRI Bio, Inc. | 10.84 Million USD | -1058.758% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -4845.736% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1546.08% |
| IGM Biosciences, Inc. | -211.66 Million USD | 159.35% |
| INmune Bio, Inc. | 155 Thousand USD | -80945.806% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -102.814% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 8439.756% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 19472.384% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 429221.405% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -31149.005% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 6393.637% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 40234.505% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -32.987% |
| Verastem, Inc. | -62 Thousand USD | 202714.516% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -5058.973% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 48230.651% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -4050.017% |
| Histogen Inc. | 3.76 Million USD | -3233.006% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -21702.426% |
| Surrozen, Inc. | -27.23 Million USD | 561.333% |
| Organovo Holdings, Inc. | -5.38 Million USD | 2431.063% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 10526.018% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 589.808% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -526.476% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 6344594.949% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -1970.759% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 187228.152% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 18.845% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -86059.808% |
| Apollomics, Inc. | 127 Thousand USD | -98814.173% |
| Amarin Corporation plc | 165.54 Million USD | 24.115% |
| Mesoblast Limited | -9.81 Million USD | 1379.888% |
| Turnstone Biologics Corp. | 16.5 Million USD | -661.063% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 213.695% |
| Synaptogenix, Inc. | -6347.00 USD | 1979318.528% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 246415.686% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 22.151% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 92.853% |
| Better Therapeutics, Inc. | -2.72 Million USD | 4703.188% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 212.001% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 62.843% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1101265.849% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 2106.725% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 11437.635% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1616.603% |
| Insmed Incorporated | 239.63 Million USD | 47.578% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -3410.928% |
| OmniAb, Inc. | 14.66 Million USD | -756.487% |
| Alector, Inc. | -95.05 Million USD | 232.159% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 389.03% |
| Zai Lab Limited | 170.9 Million USD | 26.496% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -53.426% |
| Aura Biosciences, Inc. | -1.29 Million USD | 9800.463% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -96531.538% |
| Immunic, Inc. | -111 Thousand USD | 113272.072% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -692.362% |
| Veracyte, Inc. | 248.14 Million USD | 49.377% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.797% |
| FibroGen, Inc. | 128.9 Million USD | 2.547% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 22273326.95% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1176.731% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 96.304% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -32193.316% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 64.648% |
| TG Therapeutics, Inc. | 219.1 Million USD | 42.667% |
| Galecto, Inc. | -830 Thousand USD | 15235.06% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 9170.108% |
| Fortrea Holdings Inc. | 424 Million USD | 70.372% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 245.788% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 22255.379% |
| XBiotech Inc. | -1.74 Million USD | 7303.039% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 11437.635% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 370.321% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 266.311% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -71.139% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -647.611% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 67.71% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 353.028% |
| Vaxxinity, Inc. | -2.23 Million USD | 5723.142% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 61.555% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1209.35% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -413.766% |
| NexImmune, Inc. | -1.02 Million USD | 12356.042% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -2326214.815% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 1867.902% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 98.888% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 188079.41% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 3637.623% |
| Ainos, Inc. | -253.73 Thousand USD | 49609.13% |
| Pluri Inc. | 322 Thousand USD | -38912.733% |
| Prothena Corporation plc | -129.2 Million USD | 197.229% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -149.13% |
| Celularity Inc. | 6.75 Million USD | -1759.674% |
| Rallybio Corporation | -150 Thousand USD | 83847.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 485.258% |
| MeiraGTx Holdings plc | 287 Thousand USD | -43670.383% |
| Omeros Corporation | -69.77 Million USD | 280.027% |
| Humacyte, Inc. | -76.55 Million USD | 264.103% |
| Immunocore Holdings plc | 248.39 Million USD | 49.426% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 928.143% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -101.374% |
| Blueprint Medicines Corporation | 236.58 Million USD | 46.902% |
| CalciMedica, Inc. | -58 Thousand USD | 216687.931% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 8909.327% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -332.356% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 4517.053% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 507.001% |
| Pulmatrix, Inc. | -8.22 Million USD | 1628.236% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 10836.838% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 31583.96% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 131.5% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -4425.929% |
| Cytokinetics, Incorporated | -322.59 Million USD | 138.941% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -14471.427% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 36939.003% |
| Vor Biopharma Inc. | -3.49 Million USD | 3697.394% |
| Roivant Sciences Ltd. | 109.23 Million USD | -15.001% |
| Evogene Ltd. | 1.39 Million USD | -8879.342% |
| ProKidney Corp. | -3.16 Million USD | 4064.058% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 386.074% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1732.011% |
| CorMedix Inc. | -205.56 Thousand USD | 61211.003% |
| BioLineRx Ltd. | 1.1 Million USD | -11237.635% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 259.679% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 380769.697% |
| Atai Life Sciences N.V. | -5000.00 USD | 2512520.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 103187.175% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 130955.208% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 9143.988% |
| Sagimet Biosciences Inc. | 2 Million USD | -6181.05% |
| MediciNova, Inc. | 979.7 Thousand USD | -12722.329% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 248.983% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 132954.952% |
| GeoVax Labs, Inc. | -20.72 Million USD | 706.257% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 48.629% |
| Biomea Fusion, Inc. | -4.2 Million USD | 3090.264% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 85.599% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1591.637% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 40622.903% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1046941.667% |
| Absci Corporation | -41.84 Million USD | 400.177% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2512520.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 264.484% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 5204.47% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 41.226% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 13449.734% |
| Allakos Inc. | -6.14 Million USD | 2145.611% |
| Imunon, Inc. | -720 Thousand USD | 17547.24% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 282.07% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 73.603% |
| BioAtla, Inc. | -103.73 Million USD | 221.103% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1101265.849% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 70673.596% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 151.734% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 40492.605% |
| XOMA Corporation | 3.86 Million USD | -3153.587% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 279.241% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -749.135% |
| aTyr Pharma, Inc. | -2.38 Million USD | 5360.511% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -908.194% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 433275.862% |
| Viridian Therapeutics, Inc. | -1 Million USD | 12562.401% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -966315284.615% |
| Akari Therapeutics, Plc | -4000.00 USD | 3140625.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 80.276% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -64417.637% |
| UroGen Pharma Ltd. | 73.35 Million USD | -71.258% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 570.596% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -1081906.891% |
| Orgenesis Inc. | -5.72 Million USD | 2294.253% |
| Entera Bio Ltd. | -56 Thousand USD | 224423.214% |
| GH Research PLC | -315 Thousand USD | 39979.683% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 66566.138% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 24027.81% |
| Xencor, Inc. | -85.26 Million USD | 247.339% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 56947.998% |
| Replimune Group, Inc. | -2.65 Million USD | 4831.488% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 12646.592% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 29.364% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -64417.637% |
| Portage Biotech Inc. | -54 Thousand USD | 232731.481% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 132954.952% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 33421.22% |
| OncoCyte Corporation | 413 Thousand USD | -30316.707% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 2794782.981% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 56586136.036% |
| Purple Biotech Ltd. | -196 Thousand USD | 64192.347% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1300.769% |
| scPharmaceuticals Inc. | 9.78 Million USD | -1184.206% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1302.695% |
| HilleVax, Inc. | -2.15 Million USD | 5926.577% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 129606.186% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 837350.067% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 18905.539% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 546278.261% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1673672.106% |
| Savara Inc. | -44.26 Million USD | 383.812% |
| Curis, Inc. | 9.81 Million USD | -1180.41% |
| Daré Bioscience, Inc. | 2.76 Million USD | -4435.837% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 100767.532% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 7365.529% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 55196.93% |
| BeiGene, Ltd. | 2.07 Billion USD | 93.957% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 4593.043% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 131.432% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -121.601% |
| Erasca, Inc. | -3.73 Million USD | 3466.05% |
| bluebird bio, Inc. | -4.03 Million USD | 3217.146% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 445280.381% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 93.404% |
| DBV Technologies S.A. | 15.72 Million USD | -698.709% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 445280.381% |
| Moderna, Inc. | 2.15 Billion USD | 94.171% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 13829.071% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1469.086% |
| Molecular Templates, Inc. | 50.39 Million USD | -149.273% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 23536.754% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 6.104% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 2118.981% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 419.297% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 213.042% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 3601.143% |
| MacroGenics, Inc. | 50.52 Million USD | -148.622% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 2160.036% |
| Prime Medicine, Inc. | -147.9 Million USD | 184.934% |
| Aditxt, Inc. | -111.66 Thousand USD | 112603.135% |
| Adagene Inc. | 18.11 Million USD | -593.598% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -25642.008% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 10.4% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 20.41% |
| SciSparc Ltd. | 2.19 Million USD | -5620.446% |
| Vericel Corporation | 135.57 Million USD | 7.343% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 501601.058% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 405564.463% |
| Generation Bio Co. | -73.91 Million USD | 269.963% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 28846.224% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -129.995% |
| Invivyd, Inc. | -2.02 Million USD | 6294.329% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 141.757% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 121545.697% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -30.356% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -27.809% |
| ADMA Biologics, Inc. | 88.21 Million USD | -42.398% |
| Clene Inc. | 533 Thousand USD | -23468.668% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -421.05% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 13226.541% |
| GeoVax Labs, Inc. | -20.72 Million USD | 706.257% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -6218.964% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 64747.79% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -152.226% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 1871.306% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 15126.435% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -50.598% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -171719.947% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -136.298% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 172.534% |
| Trevena, Inc. | 1.45 Million USD | -8533.746% |
| Surrozen, Inc. | -27.23 Million USD | 561.333% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 35686.686% |
| Cingulate Inc. | -582.91 Thousand USD | 21650.372% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 405329.032% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 737.702% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1659558.388% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 14358.91% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 81.545% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 12814.676% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 223061.556% |
| Kronos Bio, Inc. | 1.37 Million USD | -9056.05% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 334.079% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 43120.89% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 25825.455% |
| ImmunityBio, Inc. | -17.89 Million USD | 802.186% |
| Korro Bio, Inc. | -3.63 Million USD | 3560.634% |
| Kineta, Inc. | 5.43 Million USD | -2212.185% |
| BioVie Inc. | -229.37 Thousand USD | 54866.171% |
| Codexis, Inc. | 57.33 Million USD | -119.104% |
| Celularity Inc. | 6.75 Million USD | -1759.674% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -3030.351% |
| Celcuity Inc. | -142.77 Thousand USD | 88087.14% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -248211.919% |
| Cibus, Inc. | 1.42 Million USD | -8734.107% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 33688.503% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 648.109% |
| IN8bio, Inc. | -2.5 Million USD | 5122.831% |
| Kodiak Sciences Inc. | -25.94 Million USD | 584.145% |
| Annexon, Inc. | -3.26 Million USD | 3945.148% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 6245.841% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 400.982% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -19528.281% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 83.864% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 27.368% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 6711.632% |
| Arcellx, Inc. | 108.27 Million USD | -16.016% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 488.09% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -58.604% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 693.897% |
| Moolec Science SA | -143.3 Thousand USD | 87759.886% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 396.85% |
| Geron Corporation | -123.5 Million USD | 201.715% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -3721.752% |
| Royalty Pharma plc | 1.79 Billion USD | 92.997% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 279.228% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 3477979.291% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -54189.493% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 212.752% |
| Humacyte, Inc. | -76.55 Million USD | 264.103% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 13334.77% |
| 89bio, Inc. | -273 Thousand USD | 46115.018% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 10093.715% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 14913.797% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 102230.894% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -11126.184% |
| Notable Labs, Ltd. | 113 Thousand USD | -111069.027% |
| Liquidia Corporation | 14.6 Million USD | -760.418% |
| Mustang Bio, Inc. | -2.22 Million USD | 5745.888% |
| Immunovant, Inc. | -231 Thousand USD | 54481.385% |
| Quantum-Si incorporated | 488 Thousand USD | -25642.008% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 326.104% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 418836.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -6646.563% |
| Acasti Pharma Inc. | -11 Thousand USD | 1142109.091% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 61493.237% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 19472.384% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 174.992% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -10972.027% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 33071.391% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 6515.781% |
| PepGen Inc. | -1.18 Million USD | 10709.882% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 99014.173% |
| United Therapeutics Corporation | 2.07 Billion USD | 93.931% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 648.635% |
| Solid Biosciences Inc. | -76.56 Million USD | 264.075% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 152214.842% |
| Immuneering Corporation | -764.13 Thousand USD | 16539.57% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -189476.542% |
| Belite Bio, Inc | -399 Thousand USD | 31583.96% |
| XOMA Corporation | 3.86 Million USD | -3153.587% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 726.976% |
| Bionomics Limited | -434.44 Thousand USD | 29015.016% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 11796.555% |
| uniQure N.V. | 2.21 Million USD | -5571.377% |
| Cassava Sciences, Inc. | -89.42 Million USD | 240.48% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 236.442% |
| Forte Biosciences, Inc. | -9000.00 USD | 1395888.889% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 15144.431% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 28846.224% |
| Altimmune, Inc. | -65.37 Million USD | 292.16% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 65.301% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 11796.555% |
| Compugen Ltd. | 31.45 Million USD | -299.367% |
| Peak Bio, Inc. | 367.76 Thousand USD | -34057.583% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -412.404% |
| Benitec Biopharma Inc. | 108 Thousand USD | -116215.741% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 161152.564% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 10542.311% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 6994.676% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 105663.866% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 10542.311% |
| Instil Bio, Inc. | -4.75 Million USD | 2741.316% |
| argenx SE | 1.1 Billion USD | 88.667% |
| Immunome, Inc. | -8.9 Million USD | 1510.363% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 6746.614% |
| Verona Pharma plc | -679.62 Thousand USD | 18583.897% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 71883.429% |
| Shattuck Labs, Inc. | -2.38 Million USD | 5367.128% |
| CervoMed Inc. | -1.29 Million USD | 9810.759% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 5318.986% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 2729.705% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -4983.812% |
| Moolec Science SA | -143.3 Thousand USD | 87759.886% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 30887.197% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 4802.215% |
| AnaptysBio, Inc. | 14.78 Million USD | -749.882% |
| Design Therapeutics, Inc. | -537 Thousand USD | 23493.11% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 29519.438% |
| NeurAxis, Inc. | 2.15 Million USD | -5724.675% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -5753.728% |
| Lumos Pharma, Inc. | 2 Million USD | -6159.143% |
| Achilles Therapeutics plc | -4.73 Million USD | 2755.124% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 71883.429% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 118974.852% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -296.797% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -14471.427% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 12272.578% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 375.799% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -292041.86% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 15382.36% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 954811.962% |
| Palisade Bio, Inc. | 246 Thousand USD | -50965.447% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 380769.697% |
| Beam Therapeutics Inc. | -59.67 Million USD | 310.519% |
| Neurogene Inc. | -3.26 Million USD | 3951.042% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 9.842% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 3502.519% |
| Sesen Bio, Inc. | 40 Million USD | -214.053% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 42396.633% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 3219.44% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1413.203% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -792.195% |
| Athira Pharma, Inc. | -969 Thousand USD | 13063.983% |
| Vaccinex, Inc. | -16 Million USD | 884.935% |
| HCW Biologics Inc. | -574.82 Thousand USD | 21953.82% |
| XOMA Corporation | 3.86 Million USD | -3153.587% |
| Nektar Therapeutics | 53.47 Million USD | -134.902% |
| Arvinas, Inc. | 71.8 Million USD | -74.96% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 250.515% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 300.113% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 39112.733% |
| Rezolute, Inc. | -36 Thousand USD | 349047.222% |
| Clene Inc. | 533 Thousand USD | -23468.668% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 9783666.978% |
| BeyondSpring Inc. | 1.75 Million USD | -7074.243% |
| Synlogic, Inc. | -1.92 Million USD | 6629.158% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 339616.216% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 2083.907% |
| Peak Bio, Inc. | 367.76 Thousand USD | -34057.583% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 762.453% |
| Krystal Biotech, Inc. | 47.6 Million USD | -163.882% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 10.965% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -2399.92% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 4951.695% |
| MannKind Corporation | 136.19 Million USD | 7.761% |
| Ikena Oncology, Inc. | -50.49 Million USD | 348.794% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -15.446% |
| Gossamer Bio, Inc. | -4.38 Million USD | 2964.789% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 49949.603% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2512520.0% |
| Legend Biotech Corporation | 140.92 Million USD | 10.862% |
| Mural Oncology plc | -2.56 Million USD | 4993.689% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 22898.73% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 125721.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -505.286% |
| REGENXBIO Inc. | 53.02 Million USD | -136.891% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 2445.008% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 65400.065% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 7352.945% |
| Vaxart, Inc. | -60.76 Million USD | 306.739% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 47904.627% |
| Cellectis S.A. | 18 Thousand USD | -697794.444% |
| Longeveron Inc. | 221 Thousand USD | -56742.081% |
| Repare Therapeutics Inc. | -80.07 Million USD | 256.889% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 88.507% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 9807.96% |
| Revolution Medicines, Inc. | -399.66 Million USD | 131.432% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 359017.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -256269.388% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.54% |
| Denali Therapeutics Inc. | -93.34 Million USD | 234.577% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 501601.058% |
| Veru Inc. | 7.56 Million USD | -1560.352% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 83292.715% |
| Cingulate Inc. | -582.91 Thousand USD | 21650.372% |
| Passage Bio, Inc. | -3.72 Million USD | 3476.001% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1043117.27% |
| Exicure, Inc. | -1.42 Million USD | 8927.899% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 32899.217% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -4547.466% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 24603.048% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -84.395% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 84067.328% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 312.176% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -32028.133% |
| OmniAb, Inc. | 14.66 Million USD | -756.487% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -528.325% |
| Lipocine Inc. | -2.85 Million USD | 4506.49% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 6916.115% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 2301.946% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 8439.756% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -66.792% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 193363.077% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -49.024% |
| Ocugen, Inc. | -33.53 Million USD | 474.574% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 4072.834% |
| Q32 Bio Inc. | 578 Thousand USD | -21633.737% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 47504.151% |
| Alumis Inc. Common Stock | -1.28 Million USD | 9883.567% |
| Equillium, Inc. | 35.95 Million USD | -249.355% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 7459.168% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -24990.128% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 3038827.625% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 48602.317% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -29617.869% |
| Dominari Holdings Inc. | 2.03 Million USD | -6060.912% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 68569.131% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1024.024% |
| Bio-Techne Corporation | 773.07 Million USD | 83.75% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -625.336% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 72.738% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 10846.022% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 623.857% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -973.959% |
| Nkarta, Inc. | -5.86 Million USD | 2240.416% |
| BioCardia, Inc. | -7.24 Million USD | 1832.942% |
| Iterum Therapeutics plc | -1.75 Million USD | 7278.343% |